← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 1, 2011Last known activity
Mar 3, 2025
Timeline
2000s
- Jun 1, 2004
Vaxart— Founded
2010s
- Oct 30, 2017
Aviragen Therapeutics— Acquired
Drugs by trial phase (35 distinct, 62 trials)
Phase 4 (0 own, 3 via acquisition)
Phase 3 (0 own, 3 via acquisition)
Phase 2 (8 own, 11 via acquisition)
Indications
Subsidiaries (1 direct, 4 total across the full acquisition tree)
Recent trials (31)
- NCT06944717Lead sponsorPhase 1Mar 3, 2025
- NCT06672055Lead sponsorPhase 2Oct 8, 2024
- NCT06672055OfficialPhase 2Oct 8, 2024
- NCT07254728OfficialPhase 1Oct 27, 2023
- NCT07254728Lead sponsorPhase 1Oct 27, 2023
- NCT05626803Lead sponsorPhase 2Dec 15, 2022
- NCT05212168Lead sponsorPhase 1/Phase 2Jan 28, 2022
- NCT05213728Lead sponsorPhase 1Jan 24, 2022
- NCT05067933Lead sponsorPhase 2Oct 31, 2021
- NCT04875676Lead sponsorPhase 1/Phase 2Apr 30, 2021
- NCT04854746Lead sponsorPhase 1Apr 26, 2021
- NCT04854746Study chairPhase 1Apr 26, 2021
- NCT04563702Lead sponsorPhase 1Sep 21, 2020
- NCT03897309Lead sponsorPhase 1Mar 20, 2019
- NCT03125473Lead sponsorPhase 1Apr 7, 2017
Details
- Founded
- San Francisco, California, US Jun 1, 2004
- Last known activity
- Mar 3, 2025